nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—Triamcinolone—psoriatic arthritis	0.326	0.424	CbGbCtD
Risedronate—PTGS2—Betamethasone—psoriatic arthritis	0.28	0.364	CbGbCtD
Risedronate—PTGS2—Dexamethasone—psoriatic arthritis	0.163	0.212	CbGbCtD
Risedronate—PTGS2—Fluocinonide—Methylprednisolone—psoriatic arthritis	0.00165	0.159	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Dexamethasone—psoriatic arthritis	0.00162	0.156	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Betamethasone—psoriatic arthritis	0.00162	0.156	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Triamcinolone—psoriatic arthritis	0.00159	0.153	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.000995	0.0958	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.00098	0.0943	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.00098	0.0943	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.000957	0.0921	CbGdCrCtD
Risedronate—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000482	0.0022	CcSEcCtD
Risedronate—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00048	0.00219	CcSEcCtD
Risedronate—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000479	0.00219	CcSEcCtD
Risedronate—Arrhythmia—Triamcinolone—psoriatic arthritis	0.000476	0.00217	CcSEcCtD
Risedronate—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.000475	0.00217	CcSEcCtD
Risedronate—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00047	0.00214	CcSEcCtD
Risedronate—Depression—Prednisone—psoriatic arthritis	0.000468	0.00213	CcSEcCtD
Risedronate—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000466	0.00213	CcSEcCtD
Risedronate—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000463	0.00211	CcSEcCtD
Risedronate—Angioedema—Prednisolone—psoriatic arthritis	0.000461	0.0021	CcSEcCtD
Risedronate—Breast disorder—Methotrexate—psoriatic arthritis	0.00046	0.0021	CcSEcCtD
Risedronate—PTGS2—skeletal joint—psoriatic arthritis	0.000459	0.368	CbGeAlD
Risedronate—Vertigo—Prednisolone—psoriatic arthritis	0.000453	0.00207	CcSEcCtD
Risedronate—Syncope—Prednisolone—psoriatic arthritis	0.000452	0.00206	CcSEcCtD
Risedronate—Eye disorder—Dexamethasone—psoriatic arthritis	0.000452	0.00206	CcSEcCtD
Risedronate—Eye disorder—Betamethasone—psoriatic arthritis	0.000452	0.00206	CcSEcCtD
Risedronate—Back pain—Triamcinolone—psoriatic arthritis	0.000449	0.00205	CcSEcCtD
Risedronate—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000443	0.00202	CcSEcCtD
Risedronate—Asthma—Methotrexate—psoriatic arthritis	0.00044	0.00201	CcSEcCtD
Risedronate—Angiopathy—Dexamethasone—psoriatic arthritis	0.000439	0.002	CcSEcCtD
Risedronate—Angiopathy—Betamethasone—psoriatic arthritis	0.000439	0.002	CcSEcCtD
Risedronate—Hypertension—Prednisolone—psoriatic arthritis	0.000436	0.00199	CcSEcCtD
Risedronate—Arrhythmia—Betamethasone—psoriatic arthritis	0.000432	0.00197	CcSEcCtD
Risedronate—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000432	0.00197	CcSEcCtD
Risedronate—Angioedema—Triamcinolone—psoriatic arthritis	0.000424	0.00193	CcSEcCtD
Risedronate—Haemoglobin—Prednisone—psoriatic arthritis	0.000423	0.00193	CcSEcCtD
Risedronate—Angioedema—Methylprednisolone—psoriatic arthritis	0.000423	0.00193	CcSEcCtD
Risedronate—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000422	0.00192	CcSEcCtD
Risedronate—Haemorrhage—Prednisone—psoriatic arthritis	0.000421	0.00192	CcSEcCtD
Risedronate—Vertigo—Triamcinolone—psoriatic arthritis	0.000417	0.0019	CcSEcCtD
Risedronate—Syncope—Triamcinolone—psoriatic arthritis	0.000416	0.0019	CcSEcCtD
Risedronate—Vertigo—Methylprednisolone—psoriatic arthritis	0.000416	0.0019	CcSEcCtD
Risedronate—Syncope—Methylprednisolone—psoriatic arthritis	0.000415	0.00189	CcSEcCtD
Risedronate—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000414	0.00189	CcSEcCtD
Risedronate—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000409	0.00187	CcSEcCtD
Risedronate—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000408	0.00186	CcSEcCtD
Risedronate—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000407	0.00186	CcSEcCtD
Risedronate—Shock—Prednisolone—psoriatic arthritis	0.000405	0.00185	CcSEcCtD
Risedronate—Cough—Triamcinolone—psoriatic arthritis	0.000405	0.00185	CcSEcCtD
Risedronate—Hypertension—Triamcinolone—psoriatic arthritis	0.000401	0.00183	CcSEcCtD
Risedronate—Hypertension—Methylprednisolone—psoriatic arthritis	0.0004	0.00182	CcSEcCtD
Risedronate—Myalgia—Triamcinolone—psoriatic arthritis	0.000395	0.0018	CcSEcCtD
Risedronate—Pneumonia—Methotrexate—psoriatic arthritis	0.000394	0.0018	CcSEcCtD
Risedronate—Myalgia—Methylprednisolone—psoriatic arthritis	0.000394	0.0018	CcSEcCtD
Risedronate—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000394	0.0018	CcSEcCtD
Risedronate—Eye disorder—Prednisone—psoriatic arthritis	0.000394	0.0018	CcSEcCtD
Risedronate—Anxiety—Methylprednisolone—psoriatic arthritis	0.000393	0.00179	CcSEcCtD
Risedronate—Infestation NOS—Methotrexate—psoriatic arthritis	0.000392	0.00179	CcSEcCtD
Risedronate—Infestation—Methotrexate—psoriatic arthritis	0.000392	0.00179	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000391	0.00179	CcSEcCtD
Risedronate—Depression—Methotrexate—psoriatic arthritis	0.000391	0.00178	CcSEcCtD
Risedronate—Dry mouth—Triamcinolone—psoriatic arthritis	0.000386	0.00176	CcSEcCtD
Risedronate—Angioedema—Betamethasone—psoriatic arthritis	0.000385	0.00176	CcSEcCtD
Risedronate—Angioedema—Dexamethasone—psoriatic arthritis	0.000385	0.00176	CcSEcCtD
Risedronate—Angiopathy—Prednisone—psoriatic arthritis	0.000382	0.00174	CcSEcCtD
Risedronate—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000381	0.00174	CcSEcCtD
Risedronate—Immune system disorder—Prednisone—psoriatic arthritis	0.00038	0.00174	CcSEcCtD
Risedronate—Vertigo—Betamethasone—psoriatic arthritis	0.000378	0.00173	CcSEcCtD
Risedronate—Vertigo—Dexamethasone—psoriatic arthritis	0.000378	0.00173	CcSEcCtD
Risedronate—Syncope—Dexamethasone—psoriatic arthritis	0.000378	0.00172	CcSEcCtD
Risedronate—Syncope—Betamethasone—psoriatic arthritis	0.000378	0.00172	CcSEcCtD
Risedronate—Arrhythmia—Prednisone—psoriatic arthritis	0.000376	0.00172	CcSEcCtD
Risedronate—Infection—Triamcinolone—psoriatic arthritis	0.000376	0.00172	CcSEcCtD
Risedronate—Infection—Methylprednisolone—psoriatic arthritis	0.000375	0.00171	CcSEcCtD
Risedronate—Shock—Triamcinolone—psoriatic arthritis	0.000373	0.0017	CcSEcCtD
Risedronate—Insomnia—Prednisolone—psoriatic arthritis	0.000372	0.0017	CcSEcCtD
Risedronate—Shock—Methylprednisolone—psoriatic arthritis	0.000372	0.0017	CcSEcCtD
Risedronate—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000371	0.00169	CcSEcCtD
Risedronate—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000371	0.00169	CcSEcCtD
Risedronate—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00037	0.00169	CcSEcCtD
Risedronate—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00037	0.00169	CcSEcCtD
Risedronate—Paraesthesia—Prednisolone—psoriatic arthritis	0.00037	0.00169	CcSEcCtD
Risedronate—Mental disorder—Prednisone—psoriatic arthritis	0.000369	0.00168	CcSEcCtD
Risedronate—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000367	0.00167	CcSEcCtD
Risedronate—Malnutrition—Prednisone—psoriatic arthritis	0.000367	0.00167	CcSEcCtD
Risedronate—Hypertension—Dexamethasone—psoriatic arthritis	0.000363	0.00166	CcSEcCtD
Risedronate—Hypertension—Betamethasone—psoriatic arthritis	0.000363	0.00166	CcSEcCtD
Risedronate—Myalgia—Dexamethasone—psoriatic arthritis	0.000358	0.00164	CcSEcCtD
Risedronate—Myalgia—Betamethasone—psoriatic arthritis	0.000358	0.00164	CcSEcCtD
Risedronate—Anxiety—Betamethasone—psoriatic arthritis	0.000357	0.00163	CcSEcCtD
Risedronate—Anxiety—Dexamethasone—psoriatic arthritis	0.000357	0.00163	CcSEcCtD
Risedronate—Haemoglobin—Methotrexate—psoriatic arthritis	0.000354	0.00161	CcSEcCtD
Risedronate—Pain—Prednisolone—psoriatic arthritis	0.000352	0.00161	CcSEcCtD
Risedronate—Haemorrhage—Methotrexate—psoriatic arthritis	0.000352	0.00161	CcSEcCtD
Risedronate—Pharyngitis—Methotrexate—psoriatic arthritis	0.000349	0.00159	CcSEcCtD
Risedronate—PTGS2—synovial membrane of synovial joint—psoriatic arthritis	0.000348	0.279	CbGeAlD
Risedronate—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000348	0.00159	CcSEcCtD
Risedronate—Urethral disorder—Methotrexate—psoriatic arthritis	0.000345	0.00157	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000345	0.00157	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000344	0.00157	CcSEcCtD
Risedronate—Insomnia—Triamcinolone—psoriatic arthritis	0.000342	0.00156	CcSEcCtD
Risedronate—Insomnia—Methylprednisolone—psoriatic arthritis	0.000342	0.00156	CcSEcCtD
Risedronate—Infection—Dexamethasone—psoriatic arthritis	0.000341	0.00156	CcSEcCtD
Risedronate—Infection—Betamethasone—psoriatic arthritis	0.000341	0.00156	CcSEcCtD
Risedronate—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00034	0.00155	CcSEcCtD
Risedronate—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000339	0.00155	CcSEcCtD
Risedronate—Anaemia—Prednisone—psoriatic arthritis	0.000339	0.00155	CcSEcCtD
Risedronate—Shock—Dexamethasone—psoriatic arthritis	0.000338	0.00154	CcSEcCtD
Risedronate—Shock—Betamethasone—psoriatic arthritis	0.000338	0.00154	CcSEcCtD
Risedronate—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000338	0.00154	CcSEcCtD
Risedronate—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000337	0.00154	CcSEcCtD
Risedronate—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000337	0.00154	CcSEcCtD
Risedronate—Angioedema—Prednisone—psoriatic arthritis	0.000335	0.00153	CcSEcCtD
Risedronate—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000333	0.00152	CcSEcCtD
Risedronate—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000333	0.00152	CcSEcCtD
Risedronate—Vertigo—Prednisone—psoriatic arthritis	0.000329	0.0015	CcSEcCtD
Risedronate—Eye disorder—Methotrexate—psoriatic arthritis	0.000329	0.0015	CcSEcCtD
Risedronate—Syncope—Prednisone—psoriatic arthritis	0.000329	0.0015	CcSEcCtD
Risedronate—Tinnitus—Methotrexate—psoriatic arthritis	0.000328	0.0015	CcSEcCtD
Risedronate—Urticaria—Prednisolone—psoriatic arthritis	0.000327	0.00149	CcSEcCtD
Risedronate—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000327	0.00149	CcSEcCtD
Risedronate—Fatigue—Triamcinolone—psoriatic arthritis	0.000326	0.00149	CcSEcCtD
Risedronate—Fatigue—Methylprednisolone—psoriatic arthritis	0.000326	0.00149	CcSEcCtD
Risedronate—Pain—Triamcinolone—psoriatic arthritis	0.000324	0.00148	CcSEcCtD
Risedronate—Loss of consciousness—Prednisone—psoriatic arthritis	0.000322	0.00147	CcSEcCtD
Risedronate—Angiopathy—Methotrexate—psoriatic arthritis	0.000319	0.00146	CcSEcCtD
Risedronate—Immune system disorder—Methotrexate—psoriatic arthritis	0.000318	0.00145	CcSEcCtD
Risedronate—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000317	0.00145	CcSEcCtD
Risedronate—Hypertension—Prednisone—psoriatic arthritis	0.000317	0.00144	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000313	0.00143	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000313	0.00143	CcSEcCtD
Risedronate—Myalgia—Prednisone—psoriatic arthritis	0.000312	0.00142	CcSEcCtD
Risedronate—Arthralgia—Prednisone—psoriatic arthritis	0.000312	0.00142	CcSEcCtD
Risedronate—Anxiety—Prednisone—psoriatic arthritis	0.000311	0.00142	CcSEcCtD
Risedronate—Insomnia—Dexamethasone—psoriatic arthritis	0.000311	0.00142	CcSEcCtD
Risedronate—Insomnia—Betamethasone—psoriatic arthritis	0.000311	0.00142	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00031	0.00141	CcSEcCtD
Risedronate—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000309	0.00141	CcSEcCtD
Risedronate—Paraesthesia—Betamethasone—psoriatic arthritis	0.000309	0.00141	CcSEcCtD
Risedronate—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000309	0.00141	CcSEcCtD
Risedronate—Mental disorder—Methotrexate—psoriatic arthritis	0.000308	0.00141	CcSEcCtD
Risedronate—Malnutrition—Methotrexate—psoriatic arthritis	0.000306	0.0014	CcSEcCtD
Risedronate—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000303	0.00138	CcSEcCtD
Risedronate—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000302	0.00138	CcSEcCtD
Risedronate—Dyspepsia—Betamethasone—psoriatic arthritis	0.000302	0.00138	CcSEcCtD
Risedronate—Urticaria—Triamcinolone—psoriatic arthritis	0.000301	0.00137	CcSEcCtD
Risedronate—Urticaria—Methylprednisolone—psoriatic arthritis	0.0003	0.00137	CcSEcCtD
Risedronate—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000299	0.00137	CcSEcCtD
Risedronate—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000299	0.00136	CcSEcCtD
Risedronate—Infection—Prednisone—psoriatic arthritis	0.000297	0.00136	CcSEcCtD
Risedronate—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000297	0.00135	CcSEcCtD
Risedronate—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000297	0.00135	CcSEcCtD
Risedronate—Back pain—Methotrexate—psoriatic arthritis	0.000296	0.00135	CcSEcCtD
Risedronate—Fatigue—Betamethasone—psoriatic arthritis	0.000296	0.00135	CcSEcCtD
Risedronate—Fatigue—Dexamethasone—psoriatic arthritis	0.000296	0.00135	CcSEcCtD
Risedronate—Shock—Prednisone—psoriatic arthritis	0.000294	0.00134	CcSEcCtD
Risedronate—Pain—Dexamethasone—psoriatic arthritis	0.000294	0.00134	CcSEcCtD
Risedronate—Pain—Betamethasone—psoriatic arthritis	0.000294	0.00134	CcSEcCtD
Risedronate—Nervous system disorder—Prednisone—psoriatic arthritis	0.000293	0.00134	CcSEcCtD
Risedronate—Skin disorder—Prednisone—psoriatic arthritis	0.000291	0.00133	CcSEcCtD
Risedronate—Anaemia—Methotrexate—psoriatic arthritis	0.000283	0.00129	CcSEcCtD
Risedronate—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000281	0.00128	CcSEcCtD
Risedronate—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000281	0.00128	CcSEcCtD
Risedronate—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000279	0.00127	CcSEcCtD
Risedronate—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000278	0.00127	CcSEcCtD
Risedronate—Vertigo—Methotrexate—psoriatic arthritis	0.000275	0.00126	CcSEcCtD
Risedronate—Urticaria—Dexamethasone—psoriatic arthritis	0.000273	0.00125	CcSEcCtD
Risedronate—Urticaria—Betamethasone—psoriatic arthritis	0.000273	0.00125	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000273	0.00124	CcSEcCtD
Risedronate—Dizziness—Prednisolone—psoriatic arthritis	0.000272	0.00124	CcSEcCtD
Risedronate—Asthenia—Triamcinolone—psoriatic arthritis	0.000272	0.00124	CcSEcCtD
Risedronate—Body temperature increased—Betamethasone—psoriatic arthritis	0.000272	0.00124	CcSEcCtD
Risedronate—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000272	0.00124	CcSEcCtD
Risedronate—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000272	0.00124	CcSEcCtD
Risedronate—Abdominal pain—Betamethasone—psoriatic arthritis	0.000272	0.00124	CcSEcCtD
Risedronate—Asthenia—Methylprednisolone—psoriatic arthritis	0.000271	0.00124	CcSEcCtD
Risedronate—Insomnia—Prednisone—psoriatic arthritis	0.000271	0.00123	CcSEcCtD
Risedronate—Paraesthesia—Prednisone—psoriatic arthritis	0.000269	0.00123	CcSEcCtD
Risedronate—Pruritus—Triamcinolone—psoriatic arthritis	0.000268	0.00122	CcSEcCtD
Risedronate—Cough—Methotrexate—psoriatic arthritis	0.000267	0.00122	CcSEcCtD
Risedronate—Pruritus—Methylprednisolone—psoriatic arthritis	0.000267	0.00122	CcSEcCtD
Risedronate—Dyspepsia—Prednisone—psoriatic arthritis	0.000263	0.0012	CcSEcCtD
Risedronate—Chest pain—Methotrexate—psoriatic arthritis	0.000261	0.00119	CcSEcCtD
Risedronate—Myalgia—Methotrexate—psoriatic arthritis	0.000261	0.00119	CcSEcCtD
Risedronate—Arthralgia—Methotrexate—psoriatic arthritis	0.000261	0.00119	CcSEcCtD
Risedronate—Rash—Prednisolone—psoriatic arthritis	0.00026	0.00118	CcSEcCtD
Risedronate—Dermatitis—Prednisolone—psoriatic arthritis	0.000259	0.00118	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000259	0.00118	CcSEcCtD
Risedronate—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000259	0.00118	CcSEcCtD
Risedronate—Fatigue—Prednisone—psoriatic arthritis	0.000258	0.00118	CcSEcCtD
Risedronate—Headache—Prednisolone—psoriatic arthritis	0.000258	0.00118	CcSEcCtD
Risedronate—Constipation—Prednisone—psoriatic arthritis	0.000256	0.00117	CcSEcCtD
Risedronate—Dizziness—Triamcinolone—psoriatic arthritis	0.00025	0.00114	CcSEcCtD
Risedronate—Dizziness—Methylprednisolone—psoriatic arthritis	0.00025	0.00114	CcSEcCtD
Risedronate—Infection—Methotrexate—psoriatic arthritis	0.000248	0.00113	CcSEcCtD
Risedronate—Asthenia—Dexamethasone—psoriatic arthritis	0.000247	0.00112	CcSEcCtD
Risedronate—Asthenia—Betamethasone—psoriatic arthritis	0.000247	0.00112	CcSEcCtD
Risedronate—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000245	0.00112	CcSEcCtD
Risedronate—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000245	0.00112	CcSEcCtD
Risedronate—Nausea—Prednisolone—psoriatic arthritis	0.000245	0.00112	CcSEcCtD
Risedronate—Pruritus—Dexamethasone—psoriatic arthritis	0.000243	0.00111	CcSEcCtD
Risedronate—Pruritus—Betamethasone—psoriatic arthritis	0.000243	0.00111	CcSEcCtD
Risedronate—Skin disorder—Methotrexate—psoriatic arthritis	0.000243	0.00111	CcSEcCtD
Risedronate—Vomiting—Triamcinolone—psoriatic arthritis	0.000241	0.0011	CcSEcCtD
Risedronate—Vomiting—Methylprednisolone—psoriatic arthritis	0.00024	0.0011	CcSEcCtD
Risedronate—Rash—Triamcinolone—psoriatic arthritis	0.000239	0.00109	CcSEcCtD
Risedronate—Dermatitis—Triamcinolone—psoriatic arthritis	0.000239	0.00109	CcSEcCtD
Risedronate—Rash—Methylprednisolone—psoriatic arthritis	0.000238	0.00109	CcSEcCtD
Risedronate—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000238	0.00109	CcSEcCtD
Risedronate—Urticaria—Prednisone—psoriatic arthritis	0.000238	0.00108	CcSEcCtD
Risedronate—Headache—Triamcinolone—psoriatic arthritis	0.000237	0.00108	CcSEcCtD
Risedronate—Headache—Methylprednisolone—psoriatic arthritis	0.000237	0.00108	CcSEcCtD
Risedronate—Abdominal pain—Prednisone—psoriatic arthritis	0.000237	0.00108	CcSEcCtD
Risedronate—Body temperature increased—Prednisone—psoriatic arthritis	0.000237	0.00108	CcSEcCtD
Risedronate—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000235	0.00107	CcSEcCtD
Risedronate—Diarrhoea—Betamethasone—psoriatic arthritis	0.000235	0.00107	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000228	0.00104	CcSEcCtD
Risedronate—Dizziness—Betamethasone—psoriatic arthritis	0.000227	0.00104	CcSEcCtD
Risedronate—Dizziness—Dexamethasone—psoriatic arthritis	0.000227	0.00104	CcSEcCtD
Risedronate—Insomnia—Methotrexate—psoriatic arthritis	0.000226	0.00103	CcSEcCtD
Risedronate—Nausea—Triamcinolone—psoriatic arthritis	0.000225	0.00103	CcSEcCtD
Risedronate—Paraesthesia—Methotrexate—psoriatic arthritis	0.000225	0.00102	CcSEcCtD
Risedronate—Nausea—Methylprednisolone—psoriatic arthritis	0.000224	0.00102	CcSEcCtD
Risedronate—Dyspnoea—Methotrexate—psoriatic arthritis	0.000223	0.00102	CcSEcCtD
Risedronate—Hypersensitivity—Prednisone—psoriatic arthritis	0.00022	0.00101	CcSEcCtD
Risedronate—Dyspepsia—Methotrexate—psoriatic arthritis	0.00022	0.001	CcSEcCtD
Risedronate—Vomiting—Betamethasone—psoriatic arthritis	0.000218	0.000997	CcSEcCtD
Risedronate—Vomiting—Dexamethasone—psoriatic arthritis	0.000218	0.000997	CcSEcCtD
Risedronate—Rash—Dexamethasone—psoriatic arthritis	0.000217	0.000989	CcSEcCtD
Risedronate—Rash—Betamethasone—psoriatic arthritis	0.000217	0.000989	CcSEcCtD
Risedronate—Dermatitis—Dexamethasone—psoriatic arthritis	0.000216	0.000988	CcSEcCtD
Risedronate—Dermatitis—Betamethasone—psoriatic arthritis	0.000216	0.000988	CcSEcCtD
Risedronate—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000216	0.000985	CcSEcCtD
Risedronate—Fatigue—Methotrexate—psoriatic arthritis	0.000216	0.000984	CcSEcCtD
Risedronate—Headache—Betamethasone—psoriatic arthritis	0.000215	0.000982	CcSEcCtD
Risedronate—Headache—Dexamethasone—psoriatic arthritis	0.000215	0.000982	CcSEcCtD
Risedronate—Asthenia—Prednisone—psoriatic arthritis	0.000215	0.00098	CcSEcCtD
Risedronate—Pain—Methotrexate—psoriatic arthritis	0.000214	0.000976	CcSEcCtD
Risedronate—Pruritus—Prednisone—psoriatic arthritis	0.000212	0.000966	CcSEcCtD
Risedronate—Diarrhoea—Prednisone—psoriatic arthritis	0.000205	0.000934	CcSEcCtD
Risedronate—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000204	0.000933	CcSEcCtD
Risedronate—Nausea—Betamethasone—psoriatic arthritis	0.000204	0.000931	CcSEcCtD
Risedronate—Nausea—Dexamethasone—psoriatic arthritis	0.000204	0.000931	CcSEcCtD
Risedronate—Urticaria—Methotrexate—psoriatic arthritis	0.000199	0.000907	CcSEcCtD
Risedronate—Dizziness—Prednisone—psoriatic arthritis	0.000198	0.000903	CcSEcCtD
Risedronate—Body temperature increased—Methotrexate—psoriatic arthritis	0.000198	0.000902	CcSEcCtD
Risedronate—Abdominal pain—Methotrexate—psoriatic arthritis	0.000198	0.000902	CcSEcCtD
Risedronate—Vomiting—Prednisone—psoriatic arthritis	0.00019	0.000868	CcSEcCtD
Risedronate—Rash—Prednisone—psoriatic arthritis	0.000189	0.000861	CcSEcCtD
Risedronate—Dermatitis—Prednisone—psoriatic arthritis	0.000188	0.00086	CcSEcCtD
Risedronate—Headache—Prednisone—psoriatic arthritis	0.000187	0.000855	CcSEcCtD
Risedronate—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000184	0.000841	CcSEcCtD
Risedronate—FDPS—skin of body—psoriatic arthritis	0.000181	0.145	CbGeAlD
Risedronate—Asthenia—Methotrexate—psoriatic arthritis	0.000179	0.000819	CcSEcCtD
Risedronate—Nausea—Prednisone—psoriatic arthritis	0.000178	0.000811	CcSEcCtD
Risedronate—Pruritus—Methotrexate—psoriatic arthritis	0.000177	0.000807	CcSEcCtD
Risedronate—Diarrhoea—Methotrexate—psoriatic arthritis	0.000171	0.000781	CcSEcCtD
Risedronate—Dizziness—Methotrexate—psoriatic arthritis	0.000165	0.000755	CcSEcCtD
Risedronate—Vomiting—Methotrexate—psoriatic arthritis	0.000159	0.000726	CcSEcCtD
Risedronate—Rash—Methotrexate—psoriatic arthritis	0.000158	0.00072	CcSEcCtD
Risedronate—Dermatitis—Methotrexate—psoriatic arthritis	0.000158	0.000719	CcSEcCtD
Risedronate—Headache—Methotrexate—psoriatic arthritis	0.000157	0.000715	CcSEcCtD
Risedronate—Nausea—Methotrexate—psoriatic arthritis	0.000149	0.000678	CcSEcCtD
Risedronate—FDPS—tendon—psoriatic arthritis	0.000138	0.11	CbGeAlD
Risedronate—PTGS2—skin of body—psoriatic arthritis	6.93e-05	0.0555	CbGeAlD
Risedronate—PTGS2—tendon—psoriatic arthritis	5.27e-05	0.0423	CbGeAlD
